“EVALUACIÓN DEL TRATAMIENTO QUIRÚRGICO DEL ADENOCARCINOMA EN LA UNIÓN GASTROESOFÁGICA EN SOLCA DESDE 1 ENERO 2011 – 30 ABRIL 2018”.

Abstract

Worldwide gastric cancer has a high incidence and morbidity and mortality, in Ecuador it is the third cause of cancer death and its therapeutic approach conceives different spheres, both because of its location and its prognosis and this goes hand in hand with the possibility of be surgically resectable. The objective was to determine the surgical technique before an adenocarcinoma of the gastroesophageal junction according to the stage that provides the greatest survival. A cross-sectional, non-experimental design correlation study was conducted at the National Oncology Institute - SOLCA * "Guayaquil", from January 2011 to April 2018. All patients who underwent surgery with a diagnosis of malignant stomach tumor were included. (Adenocarcinoma) of the gastroesophageal junction with curative intent. Variables such as age, gender, oncological stage, neoadjuvant treatment, surgical, adjuvant, location, differentiation and tumor infiltration, postoperative complications and current patient situation were taken into consideration. With a population, comprised of 17 patients. The results obtained showed that, the most frequent location was Siewert Type III in eleven patients (64.7%), the majority of patients attended was stage IIII, total gastrectomy was the most used technique with 10 patients (67.9%), the reconstruction was in Roux-en-Y 70.59%, the complications were not related to the surgery, 4 patients (23.5%) had a survival of 27 months being the highest in the present study. It is concluded that total gastrectomy is the technique of choice for cancer of the gastroesophageal junction Siewert III and stages I, II and III, since after it was shown greater survival and a lower morbidity and mortality surpassing superior or polar partial gastrectomy, however, we can indicate that the forecast will be not only of the technique, but will be accompanied by the initial stage